US Patent Issued to NANJING ANJI BIOTECHNOLOGY on March 3 for "Micropeptide HMMW and application thereof" (Chinese Inventors)

ALEXANDRIA, Va., March 3 -- United States Patent no. 12,565,522, issued on March 3, was assigned to NANJING ANJI BIOTECHNOLOGY Co. LTD. (Jiangsu, China).

"Micropeptide HMMW and application thereof" was invented by Hanmei Xu (Jiangsu, China) and Mengwei Li (Jiangsu, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "A micropeptide HMMW of a new structure and an application thereof, and relates to the field of biomedical research and development is provided. The micropeptide HMMW is obtained by encoding human lncRNA, and a recombinant vector is constructed so that objective cells perform high expression on the micropeptide HMMW, which can inhibit proliferation and migration of multiple solid tumors including...